Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.52 |
| ▸ | RECQL | P46063 | 1/20 | 0.52 |
| ▸ | NFE2L2 | Q16236 | 5/20 | 0.50 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.50 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.48 |
| ▸ | TNFRSF1A | P19438 | 1/20 | 0.45 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.44 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.44 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.44 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.44 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.44 |
| ▸ | APP | P05067 | 1/20 | 0.43 |
| ▸ | FBP1 | P09467 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL79556 | 1.00 | ALDH1A1 (0.52) | ALDH1A1CYP3A4RECQLNFE2L2HSD11B1 | |
| SCHEMBL9276381 | 0.87 | ALDH1A1 (0.62) | ALDH1A1CYP3A4RECQLNFE2L2PTGS1 | |
| SCHEMBL9276383 | 0.87 | ALDH1A1 (0.62) | ALDH1A1CYP3A4RECQLNFE2L2PTGS1 | |
| SCHEMBL17862090 | 0.85 | NFE2L2 (0.59) | NFE2L2HSD11B1PTGS1TNFRSF1ATRPA1 | |
| SCHEMBL24611334 | 0.85 | HSD11B1 (0.45) | ALDH1A1CYP3A4RECQLNFE2L2HSD11B1 | |
| SCHEMBL7097682 | 0.82 | HSD11B1 (0.47) | NFE2L2HSD11B1PTGS1TNFRSF1ATRPA1 | |
| SCHEMBL7097687 | 0.82 | HSD11B1 (0.47) | NFE2L2HSD11B1PTGS1TNFRSF1ATRPA1 | |
| SCHEMBL28837412 | 0.79 | PTGS1 (0.57) | NFE2L2HSD11B1PTGS1ALOX5PTGS2 | |
| SCHEMBL1830641 | 0.79 | HSD11B1 (0.44) | NFE2L2HSD11B1PTGS1TNFRSF1ATRPA1 | |
| SCHEMBL3872787 | 0.78 | NPC1 (0.47) | ALDH1A1CYP3A4RECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 97 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117142916-B | Preparation method of allyl sulfone compound | 安徽金桐精细化学有限公司 | 2024-10-11 | — | — | CN | claimed |
| CN-117142916-A | Preparation method of allyl sulfone compound | 安徽金桐精细化学有限公司 | 2023-12-01 | — | — | CN | claimed |
| CN-114773229-A | 1,6 diene compound and preparation method and application thereof | 南京工业大学 | 2022-07-22 | — | — | CN | claimed |
| CN-113277963-A | Amine compound and preparation method and application thereof | 南京工业大学 | 2021-08-20 | — | — | CN | claimed |
| CN-110627693-B | Allyl sulfone compound and preparation method and application thereof | 南京工业大学 | 2021-06-04 | — | — | CN | claimed |
| CN-110627693-A | Allyl sulfone compound and preparation method and application thereof | 南京工业大学 | 2019-12-31 | — | — | CN | claimed |
| EP-1284977-B1 | THIENODIBENZOAZULENE COMPOUNDS AS TUMOR NECROSIS FACTOR INHIBITORS | GLAXOSMITHKLINE ZAGREB (HR) | 2009-06-24 | — | — | EP | claimed |
| US-20050171091-A1 | Thienodibenzoazulene compounds as tumor necrosis factor inhibitors | PLIVA D.D. (HR) | 2005-08-04 | — | — | US | claimed |
| US-6897211-B2 | Thienodibenzoazulene compounds as tumor necrosis factor inhibitors | PLIVA-ISTRAZIVACKI INSTITUT D.O.O. (HR) | 2005-05-24 | — | — | US | claimed |
| US-20030153750-A1 | Thienodibenzoazulene compounds as tumor necrosis factor inhibitors | PLIVA FARMACEUTSKA INDUSTRIJA, DIONICKO DRUSTVO | 2003-08-14 | — | — | US | claimed |
| US-20250051299-A1 | PRODUCTION METHOD FOR FLUOROMETHYL DERIVATIVE | DAIKIN INDUSTRIES, LTD. (JP) | 2025-02-13 | — | — | US | disclosed |
| US-12162854-B2 | Production method for fluoromethyl derivative | DAIKIN INDUSTRIES, LTD. (JP) | 2024-12-10 | — | — | US | disclosed |
| US-12145927-B2 | Inhibitors of indoleamine 2,3-dioxygenase and methods of their use | BRISTOL-MYERS SQUIBB COMPANY (US) | 2024-11-19 | — | — | US | disclosed |
| CN-117142916-B | Preparation method of allyl sulfone compound | 安徽金桐精细化学有限公司 | 2024-10-11 | — | — | CN | disclosed |
| CN-114773229-B | 1,6 Diene compound and preparation method and application thereof | 南京工业大学 | 2024-06-14 | — | — | CN | disclosed |
| EP-1323716-A1 | PROMOTERS FOR THE PROLIFERATION AND DIFFERENTIATION OF STEM CELLS AND/OR NEURON PRECURSOR CELLS | Takeda Chemical Industries, Ltd. (JP) | 2003-07-02 | — | — | EP | disclosed |
| US-6479536-B1 | Benzofuran derivatives, process for the preparation of the same and uses thereof | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 2002-11-12 | — | — | US | disclosed |
| US-20020160996-A1 | Benzofuran derivatives, their production and use | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2002-10-31 | — | — | US | disclosed |
| EP-1136477-A1 | BENZOFURAN DERIVATIVES, PROCESS FOR THE PREPARATION OF THE SAME AND USES THEREOF | Takeda Chemical Industries, Ltd. (JP) | 2001-09-26 | — | — | EP | disclosed |
| EP-0350012-A2 | Antiviral composition | MEIJI SEIKA KAISHA LTD. (JP) | 1990-01-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030153750-A1 | Thienodibenzoazulene compounds as tumor necrosis factor inhibitors | TNF, IL1B, IL1A | ALDH1A1 48/4885CYP3A4 1915/4885RECQL 3933/4885 |
| US-12145927-B2 | Inhibitors of indoleamine 2,3-dioxygenase and methods of their use | IDO1, IDO2, INMT | ALDH1A1 508/4885CYP3A4 506/4885RECQL 2087/4885 |
| US-12162854-B2 | Production method for fluoromethyl derivative | AFF1, AFF2, ROS1 | ALDH1A1 111/4885CYP3A4 79/4885RECQL 4415/4885 |
| US-20050171091-A1 | Thienodibenzoazulene compounds as tumor necrosis factor inhibitors | TNF, IL1B, IL1A | ALDH1A1 58/4885CYP3A4 1838/4885RECQL 3780/4885 |
| US-20250051299-A1 | PRODUCTION METHOD FOR FLUOROMETHYL DERIVATIVE | AFF1, AFF2, ROS1 | ALDH1A1 111/4885CYP3A4 79/4885RECQL 4415/4885 |
| US-20020160996-A1 | Benzofuran derivatives, their production and use | PARK7, WDR1, WHR1 | ALDH1A1 311/4885CYP3A4 126/4885RECQL 932/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.